Brought to you by 
VI Technologies merges with Panacos Pharmaceuticals
15 Jul 2004
Executive Summary
VI Technologies (Vitex; develops products that reduce pathogens in the blood) is merging with privately held Panacos Pharmaceuticals, a developer of small-molecule drugs for HIV and other viral diseases.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Earnout
- Intra-Biotech Deal
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com